Loading...
XNYSMD
Market cap1.09bUSD
Jan 08, Last price  
12.73USD
1D
0.95%
1Q
6.08%
Jan 2017
-80.90%
Name

Pediatrix Medical Group Inc

Chart & Performance

D1W1MN
XNYS:MD chart
P/E
P/S
0.55
EPS
Div Yield, %
0.00%
Shrs. gr., 5y
-2.14%
Rev. gr., 5y
-11.37%
Revenues
1.99b
+1.15%
619,629,000693,700,000818,554,000917,644,0001,068,277,0001,288,264,0001,401,559,0001,588,248,0001,816,612,0002,154,012,0002,438,913,0002,779,996,0003,183,159,0003,458,312,0003,647,123,0003,513,542,0001,733,951,0001,911,191,0001,972,021,0001,994,640,000
Net income
-60m
L
98,279,00089,037,000124,465,000142,722,000169,201,000175,804,000202,691,000217,997,000240,907,000280,517,000317,281,000336,320,000324,914,000320,372,000268,629,000-1,150,094,000-9,580,000130,964,00066,335,000-60,408,000
CFO
137m
-17.74%
123,753,000162,418,000177,272,000188,522,000181,391,000241,374,000240,558,000271,019,000325,692,000405,398,000422,641,000368,701,000443,778,000511,378,000289,925,000346,637,000204,620,00076,737,000166,941,000137,325,000
Earnings
Feb 18, 2025

Profile

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.
IPO date
Sep 20, 1995
Employees
5,250
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
1,994,640
1.15%
1,972,021
3.18%
Cost of revenue
1,800,617
1,736,385
Unusual Expense (Income)
NOPBT
194,023
235,636
NOPBT Margin
9.73%
11.95%
Operating Taxes
12,049
18,806
Tax Rate
6.21%
7.98%
NOPAT
181,974
216,830
Net income
(60,408)
-191.07%
66,335
-49.35%
Dividends
Dividend yield
Proceeds from repurchase of equity
3,993
(83,115)
BB yield
-0.52%
6.65%
Debt
Debt current
59,478
36,487
Long-term debt
743,214
782,883
Deferred revenue
33,638
Other long-term liabilities
281,836
297,673
Net debt
624,949
716,307
Cash flow
Cash from operating activities
137,325
166,941
CAPEX
(33,328)
(29,708)
Cash from investing activities
(48,176)
(56,954)
Cash from financing activities
(25,715)
(487,554)
FCF
85,030
218,355
Balance
Cash
177,743
9,824
Long term investments
93,239
Excess cash
78,011
4,462
Stockholders' equity
(150,845)
(91,969)
Invested Capital
2,006,879
2,017,226
ROIC
9.04%
9.78%
ROCE
10.26%
12.03%
EV
Common stock shares outstanding
82,201
84,121
Price
9.30
-37.42%
14.86
-45.39%
Market cap
764,469
-38.84%
1,250,038
-46.47%
EV
1,389,418
1,966,345
EBITDA
230,194
271,272
EV/EBITDA
6.04
7.25
Interest
42,075
39,695
Interest/NOPBT
21.69%
16.85%